Category: Patent Added

New patent for Nevakar Injectables drug NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE

   March 15, 2023    Comments Off on New patent for Nevakar Injectables drug NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE    Posted in: Patent Added

Annual Drug Patent Expirations for NOREPINEPHRINE+BITARTRATE+IN+0.9%25+SODIUM+CHLORIDE Norepinephrine Bitartrate In 0.9% Sodium Chloride is a drug marketed by Inforlife and Nevakar Injectables and is included in two NDAs. It is available…
The post New …

Continue reading

New patent for Palatin Technologies drug VYLEESI (AUTOINJECTOR)

   March 14, 2023    Comments Off on New patent for Palatin Technologies drug VYLEESI (AUTOINJECTOR)    Posted in: Patent Added

Annual Drug Patent Expirations for VYLEESI+%28AUTOINJECTOR%29 Vyleesi (autoinjector) is a drug marketed by Palatin Technologies and is included in one NDA. It is available from one supplier. There are four…
The post New patent for Palatin Technologies …

Continue reading
Biotechblog